Universe Pharmaceuticals INC
UPC
$4.91
-$0.21-4.10%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.19M | 2.19M | -6.55M | -6.55M | -2.93M |
| Total Depreciation and Amortization | 118.40K | 118.40K | 124.40K | 124.40K | 125.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.14M | -5.14M | 5.54M | 5.54M | 132.90K |
| Change in Net Operating Assets | -702.00K | -702.00K | -327.00K | -327.00K | 833.40K |
| Cash from Operations | -3.54M | -3.54M | -1.21M | -1.21M | -1.84M |
| Capital Expenditure | -89.10K | -89.10K | -33.80K | -33.80K | -21.80K |
| Sale of Property, Plant, and Equipment | 900.00 | 900.00 | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -58.60K | -58.60K | 0.00 | 0.00 | -- |
| Cash from Investing | -146.80K | -146.80K | -33.80K | -33.80K | -21.80K |
| Total Debt Issued | 3.66M | 3.66M | 3.59M | 3.59M | 1.22M |
| Total Debt Repaid | -2.22M | -2.22M | -555.10K | -555.10K | -2.96M |
| Issuance of Common Stock | 12.50M | 12.50M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.94M | 13.94M | 3.03M | 3.03M | -1.74M |
| Foreign Exchange rate Adjustments | 60.10K | 60.10K | 2.90K | 2.90K | -236.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.32M | 10.32M | 1.79M | 1.79M | -3.83M |